Asuragen Inc-Product Pipeline Analysis, 2017 Update
April 2017
29
About the Report
About the Report
Summary
Asuragen Inc (Asuragen) is a provider of laboratory medicine solutions. The company offers products which include amplidex, quantidex, and custom reagents. It offers custom and companion diagnostic services which include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. The company's custom reagents comprise armored reagents, in vitro transcribed RNA and plasmid DNA kits. It distributes its products in Algeria, Australia, Austria, Belgium, Brazil, Bulgaria, Denmark, Egypt, Germany, Iceland, India, the UAE, the UK and the US, among others. Asuragen is headquartered in Austin, Texas, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Asuragen Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Products
Products
Asuragen Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Asuragen Inc Company Overview 4
Asuragen Inc Company Snapshot 4
Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Asuragen Inc-Pipeline Analysis Overview 7
Asuragen Inc-Key Facts 7
Asuragen Inc-Major Products and Services 8
Asuragen Inc Pipeline Products by Development Stage 9
Asuragen Inc Pipeline Products Overview 11
Diagnostic Test-Neurodegenerative Disorders 11
Diagnostic Test-Neurodegenerative Disorders Product Overview 11
miRNA Based Sequencing Test- Esophageal Cancer 12
miRNA Based Sequencing Test- Esophageal Cancer Product Overview 12
miRNA Based Sequencing Test-Colon Cancer 13
miRNA Based Sequencing Test-Colon Cancer Product Overview 13
miRNA Based Sequencing Test-Lung Cancer 14
miRNA Based Sequencing Test-Lung Cancer Product Overview 14
miRNA Based Sequencing Test-Pancreatic Cancer 15
miRNA Based Sequencing Test-Pancreatic Cancer Product Overview 15
Signature CF Expand 16
Signature CF Expand Product Overview 16
Asuragen Inc-Key Competitors 17
Asuragen Inc-Key Employees 18
Asuragen Inc-Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Asuragen Inc, Recent Developments 20
Apr 25, 2017: Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio 20
Mar 14, 2017: Asuragen Launches the AmplideX PCR/CE TOMM40 Kit Expanding Portfolio into the Alzheimer's and Cognitive Impairment Space 20
Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit 20
Aug 09, 2016: Asuragen Develops Armored RNA Quant Zika Virus Control 21
Jul 25, 2016: Asuragen's QuantideX qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance For Monitoring Minimal Residual Disease In Chronic Myeloid Leukemia 22
Jul 06, 2016: Asuragen Launches the AmplideX PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia 22
Apr 18, 2016: Asuragen to Present Expansion of Next-Generation Sequencing Portfolio at American Association for Cancer Research Annual Meeting 23
Nov 05, 2015: Asuragen Launches Amplidex PCR/CE FMR1 Reporter, A Fully Automated Software Solution For Accurate Sizing Of The FMR1 CGG Repeat Region 23
Jul 08, 2015: Asuragen Launches the Quantidex Pan Cancer Kit, a Workflow Solution for Targeted Next-Generation Sequencing 24
Jun 11, 2015: Asuragen Announces Launch of Highly Sensitive CE-IVD BCR-ABL Assay at the European Hematology Association Annual Congress 25
Appendix 26
Methodology 26
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Figure
List of Figures
Asuragen Inc Pipeline Products by Equipment Type 5
Asuragen Inc Pipeline Products by Development Stage 9
List of Table
List of Tables
Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Asuragen Inc Pipeline Products by Equipment Type 5
Asuragen Inc Pipeline Products by Indication 6
Asuragen Inc, Key Facts 7
Asuragen Inc, Major Products and Services 8
Asuragen Inc Number of Pipeline Products by Development Stage 9
Asuragen Inc Pipeline Products Summary by Development Stage 10
Diagnostic Test-Neurodegenerative Disorders-Product Status 11
Diagnostic Test-Neurodegenerative Disorders-Product Description 11
miRNA Based Sequencing Test- Esophageal Cancer-Product Status 12
miRNA Based Sequencing Test- Esophageal Cancer-Product Description 12
miRNA Based Sequencing Test-Colon Cancer-Product Status 13
miRNA Based Sequencing Test-Colon Cancer-Product Description 13
miRNA Based Sequencing Test-Lung Cancer-Product Status 14
miRNA Based Sequencing Test-Lung Cancer-Product Description 14
miRNA Based Sequencing Test-Pancreatic Cancer-Product Status 15
miRNA Based Sequencing Test-Pancreatic Cancer-Product Description 15
Signature CF Expand-Product Status 16
Signature CF Expand-Product Description 16
Asuragen Inc, Key Employees 18
Glossary 27
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.